Prevalence of night-time dyspnoea in COPD and its implications for prognosis

European Respiratory Journal

Volumn 43, Issue 6, 2014, Pages 1590-1598

  Lange, Peter ^a,b,c,d   Marott, Jacob Louis ^c   Vestbo, Jørgen ^e,f   Nordestgaard, Børge Gørnne ^c,d,g  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHITIS; CHRONIC MUCUS HYPERSECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DAYTIME DYSPNEA; DENMARK; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL SCALE; MORTALITY; NERVOUSNESS; NIGHT TIME DYSPNEA; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; STRESS; WHEEZING; ABNORMAL RESPIRATORY SOUND; COMPLICATION; EPIDEMIOLOGY; HEART MUSCLE ISCHEMIA; MENTAL STRESS; MIDDLE AGED; MUCUS; PROPORTIONAL HAZARDS MODEL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SLEEP DISORDERS; TIME; TREATMENT OUTCOME;

AGED; DENMARK; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCUS; MYOCARDIAL ISCHEMIA; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY SOUNDS; SLEEP DISORDERS; STRESS, PSYCHOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901827415     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00196713     Document Type: Article

References (18)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. www.ginasthma.org/local/uploads/files/GINA-Report-March13.pdf Date last updated: 2012.
2. Jones P, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J 2009; 34: 648-654.
3. Augusti A, Hedner J, Marin JM, et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev 2011; 121: 183-194.
4. Appleyard M. The Copenhagen City Heart Study. Scand J Soc Med, 1989: Suppl. 41, 1-160.
5. Lange P, Mogelvang R, Marott JL, et al. Cardiovascular morbidity in COPD: a study of the general population. COPD 2010; 7: 5-10.
6. Stender S, Frikke-Smidth R, Nordestgaard BG, et al. Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population. Hepatology 2011; 53: 640-648.
7. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
8. Løkke A, Marott JL, Mortensen J, et al. New Danish reference values for spirometry. Clin Respir J 2013; 7: 153-167.
9. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification. Am J Respir Crit Care Med 2012; 186: 975-981.
10. Thomsen M, Marott JL, Ingebrigtsen TS, et al. Inflammatory biomarkers in chronic obstructive pulmonary disease. JAMA 2013; 309: 2353-2361.
11. Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997; 44: 445-448. (Pubitemid 27382061)
12. The Comprehensive R Archive Network. http://cran.r-project.org/ Date last accessed: May 21, 2013. Date last updated: September 25, 2013.
13. Omachi TA, Blanc PD, Claman DM, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med 2012; 13: 476-483.
14. Price D, Small M, Milligan G. The prevalence and impact of nighttime symptoms in COPD patients - results from a cross-sectional study in five European countries. Proceedings of the IV World Asthma and COPD Forum (Paris, France, April 30 to May 3, 2011).
15. Anzueto A, Ferguson GT, Feldman G, et al. Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. COPD 2009; 6: 320-329.
16. Tashkin DP, Rennard SI, Martin P, et al. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Drugs 2008; 68: 1975-2000.
17. Balkin TJ, Rupp T, Picchioni D, et al. Sleep loss and sleepiness: current issues. Chest 2008; 134: 653-660.
18. Thomsen RW, Lange P, Hellquist B, et al. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 2011; 105: 1063-1068.